Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

Université de Montréal

$105,000.00

Maturation of microRNAs targeting alpha-synuclein : a new therapeutic avenue for Parkinson's disease

EF 2023-24

Résumé
Ribonucleic acids (RNA) have various roles in the cell, canonically in the expression of proteins. Work in the RNA field presented new non-coding roles for various RNA molecules. Among these RNA molecules, microRNAs constitute an important class of small RNA molecules playing a central role in the regulation of gene expression. In the nervous system, microRNAs are known to play e roles in the neurons function and development. Studies have correlated an altered level of microRNAs in neuronal cells to in Parkinson's disease. The level of particular microRNAs could be associated with the disease, those that target the alpha-synuclein RNA, a protein widely expressed among the neurons. The microRNAs targeting the alpha-synuclein have been shown to be lowered, leading to an accumulation of alpha-synuclein. In Parkinson's disease, the level of alpha-synuclein is increased, leading to an aggregation of the protein and contributing to the disease establishment. Thereby, there is essential to understand how these microRNAs are regulated. We hypothesize that microRNAs and associated proteins play a role in the regulation of levels of alpha- synuclein in neurons. Our studies will open new opportunities for identifying new biomarkers, mainly by the identification of new proteins and microRNAs regulating alpha-synuclein in Parkinson's disease.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
496941
Name
Gauthier-Naud William
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Maturation of microRNAs targeting alpha-synuclein : a new therapeutic avenue for Parkinson's disease
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Alpha-Synuclein; Dopaminergic; Microrna; Neurons; Parkinson'S; Rna Binding Protein
Abstract
Ribonucleic acids (RNA) have various roles in the cell, canonically in the expression of proteins. Work in the RNA field presented new non-coding roles for various RNA molecules. Among these RNA molecules, microRNAs constitute an important class of small RNA molecules playing a central role in the regulation of gene expression. In the nervous system, microRNAs are known to play e roles in the neurons function and development. Studies have correlated an altered level of microRNAs in neuronal cells to in Parkinson's disease. The level of particular microRNAs could be associated with the disease, those that target the alpha-synuclein RNA, a protein widely expressed among the neurons. The microRNAs targeting the alpha-synuclein have been shown to be lowered, leading to an accumulation of alpha-synuclein. In Parkinson's disease, the level of alpha-synuclein is increased, leading to an aggregation of the protein and contributing to the disease establishment. Thereby, there is essential to understand how these microRNAs are regulated. We hypothesize that microRNAs and associated proteins play a role in the regulation of levels of alpha- synuclein in neurons. Our studies will open new opportunities for identifying new biomarkers, mainly by the identification of new proteins and microRNAs regulating alpha-synuclein in Parkinson's disease.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gauthier-Naud, William
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~